INS and Hyperglycemia: T2DM is characterized by defective insulin secretion by pancreatic β cells and tissue resistance to insulin responses, causing hyperglycemia, hyperinsulinemia, increased reactive oxygen species (ROS), oxidative stress, and adipose tissue hypertrophy, among other metabolic changes [3,4].